Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.18817 | 7 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.16983 | 7 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.17036 | 7 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.1246 | 7 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.12335 | 7 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.22604 | 8 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.19633 | 8 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.14725 | 7 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.42125 | 18 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.15872 | 7 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.15572 | 7 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.15207 | 8 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.17483 | 8 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.45132 | 19 |